Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Recruiting 4Not yet recruiting 2Active not recruiting 2Completed 1Approved for marketing 1

Sponsor Class

OTHER 2NETWORK 1INDUSTRY 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

CNS 4

Conditions

Glioma 3Brain Neoplasms 1Astrocytoma 1

Interventions

pembrolizumab 567Specimen Handling 487Carboplatin 456Magnetic Resonance Spectroscopy 442Cyclophosphamide 418Cisplatin 412Radiotherapy 353Gemcitabine 318Bevacizumab 317Paclitaxel 304Biopsy 291Drug Therapy 286Blood Specimen Collection 249Capecitabine 244Oxaliplatin 242fludarabine 238Nivolumab 236venetoclax 227Injections 214Docetaxel 209Fluorouracil 204Dexamethasone 187Radiosurgery 182Rituximab 162Pemetrexed 160Standard of Care 156Surgical Procedures, Operative 148durvalumab 146atezolizumab 146tislelizumab 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × vorasidenib × Clear all
NCT06809322 2026-05-22

VIGOR

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting
468 enrolled
CNS

Astrocytoma

NCT07547163 2026-04-23

LGG PRO's

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

Recruiting
90 enrolled
CNS

Glioma

NCT07240662 2026-01-09

VIOLETA

iOMEDICO AG

Recruiting
150 enrolled
CNS

Glioma

NCT05609994 2025-07-18

ViCToRy

Duke University

Phase 1 Recruiting
48 enrolled
CNS

Brain Neoplasms, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡